Form D — Illuminare Biotechnologies Inc
0001701523-26-000003 · filed Jun 4, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,000,000
- Total sold
- $3,650,000
- Minimum investment
- $1,363
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Illuminare Biotechnologies Inc
- CIK
- 1701523
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 327 St Marks Avenue
Brooklyn, NY 11238 - Phone
- 6094971282
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Graifman · DirectorMiami Beach, FL Find on LinkedIn ↗
-
Oliver Curme · DirectorChestnut Hill, MA Find on LinkedIn ↗
-
Shay Grinfeld · DirectorHoboken, NJ Find on LinkedIn ↗
-
Walter Greenblatt · Executive OfficerBrooklyn, NY Find on LinkedIn ↗
-
Eric Edidin · DirectorFort Lauderdale, FL Find on LinkedIn ↗
-
Brian Longstreet · Executive OfficerWestfield, NJ Find on LinkedIn ↗
-
Andrew Fradkin · PromoterKetchum, ID Find on LinkedIn ↗
-
Ezra Angrist · PromoterCohoes, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗